MICROBIOTIX
MicrobiotiX strives to develop treatments
for global intractable diseases such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer
CMO SERVICE
Phage, Microbiome
& Beyond
MICROBIOTIX
MicrobiotiX strives to develop treatments
for global intractable diseases such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer
CMO SERVICE
Phage, Microbiome
& Beyond
Global Top 10 Bacteriophage Production with Optimized CMC Controls
(QbD process applied)
The GMP plant is responsible for the mass production of medicine to be used in clinical trials (phage treatments) currently under research and development. It aims to produce high-purity medicine through strict compliance and thorough quality control.
GMP
Good Manufacturing Practice
GMP embodies various conditions for manufacturing high-quality medicine and is a norm that should be observed throughout the quality management process, from the arrival of raw materials to the shipment of the final product.We aim to manufacture high-quality pharmaceuticals with high stability by eliminating human errors that may occur in the pharmaceutical manufacturing process, along with minimizing contamination through automated manufacturing facilities and strict process control.
CMC
Optimization
QbD based Bacteriophage Product characterization
Process optimization Drug substance development GMP documentation
Bacteriophage production Establishment of professional manpower
BACTERIOPHAGE
PRODUCTION
PROCESS
![]() |
01 Bacteriophage |
![]() |
02 Phage culturing |
![]() |
03 Phage concentration |
![]() |
04 Removal |
![]() |
05 Drug substance put |
![]() |
06 Automatic |
![]() |
07 Manufacturing drug product |
GMP
Incubation Room
30L (Fermenter) incubator
automatic sterilization system (SIP) applied
Refinery
TFF membrane (phage concentration)
IEX Chromatography (removal of Endotoxin)
Charging Room
Grade A(within the automatic vial filling machine) Production Management
10R, 10ml vial automatic filling Production CAPA: around 200,000 vials/monthly
Quality Control Laboratory
Microplate reader (Endotoxin)
Microplate reader (ELISA)
Real time PCR
Microbiology Lab (BSC)
MICROBIOTIX
Quality Assurance
The quality department of MicrobiotiX operates independently from the production department, the quality department is responsible for ensuring that all cGMP processes meet the regulatory agency’s guidelines and requirements.
Quality System
All cGMP processes are followed to adhere to all regulatory guidelines and requirements. The quality department at MicrobiotiX ensures that all systems and equipment are maintained during the cGMP production period through the quality system in place to produce high quality products.
Document System
Introduction of the document management system.
MicrobiotiX operates a document management system for the controlled creation, approval, and storage of all cGMP-related documents.
MICROBIOTIX
Quality Control
MicrobiotiX adheres to a strict quality control policies that meet global GMP regulations. We focus on delivering the highest quality products and services to our customers. This starts with ensuring high quality processes and facility operations are maintained. Our company policies are to have personal responsibility to maintain regulatory standards, promote a culture of quality compliance, and maintain world-class quality. Our leadership supports, recognizes, and rewards quality excellence. MicrobiotiX conducts risk assessments that can affect our product’s quality, stability, and/or efficacy by applying the ICH Q9 Quality Risk Management and ICH Q10 Pharmaceutical Quality System to the scientific information and data accumulated during development.
![]() | Risk assessment analysis - Equipment |
![]() | Education and document completion Managing & determining the level of equipment |
![]() | Monitoring - Deviation |
![]() | Product quality evaluation - Quality standards |
![]() | Improvement - Immediate measures to prevent issues |
Quality Management Testing Capabilities
Throughout the production process, the quality control team conducts quality tests on all samples, including raw materials, in-process, DS/DP, and stability tests. In addition, the customer has the ability to transfer testing methods and perform testing method verification in accordance with the FDA, EMA, and PMDA requirements along with the ICH Q2(R1) guidelines. MicrobiotiX maintains an optimal working environment for producing high-quality products by routinely testing facility-related samples such as environment monitoring, water and steam quality, and clean gas systems. All tests are conducted in accordance with strict cGMP requirements. In addition various tests are routinely conducted to maintain an optimal working environment for producing products. For example, environmental monitoring, testing of the purified water for injection are conducted to sustain the optimal working environment
1. Real time PCR (DNA dose)
2. Host cell Protein (ELISA)
3. Endotoxin Test
1. Sterility Test
2. Titer measurement
3. Microbial limit test
Environment
Monitoring
Consignment production
of Drug Substance (DS)
and Drug Product (DP)
MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.
Aseptic filling
Small/Large commercial and clinical
vials and syringes (10R, 10ml per vial)
Bacteriophage based biological and chemical formulations
Pre-shipment
inspection
and packaging
Foreign substance inspection
Labeling and custom packaging
Quality control and storage
application of pharmaceutical quality system (ICH Q10)
Storage: refrigerated (2~4C), it is possible to store up to (-80C)
CMO SERVICE
01
We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials.
02
Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product.
03
MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how.
MICROBIOTIX
MicrobiotiX strives to develop treatments
for global intractable diseases such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer
CMO SERVICE
Phage, Microbiome
& Beyond
CMO SERVICE PROCEDURE
![]() 01 ![]() Service | ![]() 02 ![]() Consultation |
![]() 03 ![]() Confidential | ![]() 04 ![]() Technical |
![]() 05 ![]() Product request | ![]() 06 ![]() Contract |
![]() 07 ![]() Technology | ![]() 08 ![]() Production |
Consulting Service applications are now available through our online platform. For inquiries, please contact microbiotix.cmo@microbiotix.net We are here to assist and will respond promptly Tel. 82-2-6379-2649 |
Global Top 10 Bacteriophage Production
with Optimized CMC Controls (QbD process applied)
The GMP plant is responsible for the mass production of medicine to be used in clinical trials (phage treatments) currently under research and development. It aims to produce high-purity medicine through strict compliance and thorough quality control.
GMPGood Manufacturing Practice
GMP embodies various conditions for manufacturing high-quality medicine and is a norm that should be observed throughout the quality management process, from the arrival of raw materials to the shipment of the final product.We aim to manufacture high-quality pharmaceuticals with high stability by eliminating human errors that may occur in the pharmaceutical manufacturing process, along with minimizing contamination through automated manufacturing facilities and strict process control.
CMC
Optimization
QbD based Bacteriophage |
Process optimization Drug substance development GMP documentation |
Bacteriophage production Establishment of professional manpower |
Bacteriophage Production Process
![]() | 01 Bacteriophage |
![]() | 02 Phage culturing |
![]() | 03 Phage concentration |
![]() | 04 Removal |
![]() | 05 Drug substance put |
![]() | 06 Automatic |
![]() | 07 Manufacturing drug product |
GMP
GMP Incubation Room 30L (Fermenter) incubator | ![]() | ![]() |
GMP Refinery TFF membrane (phage concentration) | ![]() | ![]() |
GMP Charging Room Grade A(within the automatic vial filling machine) Production Management | ![]() | ![]() |
GMP Quality Control Laboratory Microplate reader (Endotoxin) | ![]() | ![]() |
MICROBIOTIX
Quality Assurance
The quality department of MicrobiotiX operates independently from the production department, the quality department is responsible for ensuring that all cGMP processes meet the regulatory agency’s guidelines and requirements.
Quality System | All cGMP processes are followed to adhere to all regulatory guidelines and requirements. The quality department at MicrobiotiX ensures that all systems and equipment are maintained during the cGMP production period through the quality system in place to produce high quality products. |
Materials System |
Production System |
Packaging & Labeling System |
Facilities & Equipment System |
Laboratory Control System |
Document System | Introduction of the document management system. MicrobiotiX operates a document management system for the controlled creation, approval, and storage of all cGMP-related documents. |
01 Governance |
02 Policy |
03 Directive |
04 Forms and Worksheets |
05 Standard Operating Procedure |
MICROBIOTIX
Quality Control
MicrobiotiX adheres to a strict quality control policies that meet global GMP regulations. We focus on delivering the highest quality products and services to our customers. This starts with ensuring high quality processes and facility operations are maintained. Our company policies are to have personal responsibility to maintain regulatory standards, promote a culture of quality compliance, and maintain world-class quality. Our leadership supports, recognizes, and rewards quality excellence. MicrobiotiX conducts risk assessments that can affect our product’s quality, stability, and/or efficacy by applying the ICH Q9 Quality Risk Management and ICH Q10 Pharmaceutical Quality System to the scientific information and data accumulated during development.
![]() Risk | - Equipment |
![]() Education | Managing & determining the level of equipment |
![]() Monitoring | - Deviation |
![]() Improvement | - Immediate measures to prevent issues |
![]() Product | - Quality standards |
Quality Management Testing Capabilities | Throughout the production process, the quality control team conducts quality tests on all samples, including raw materials, in-process, DS/DP, and stability tests. In addition, the customer has the ability to transfer testing methods and perform testing method verification in accordance with the FDA, EMA, and PMDA requirements along with the ICH Q2(R1) guidelines. MicrobiotiX maintains an optimal working environment for producing high-quality products by routinely testing facility-related samples such as environment monitoring, water and steam quality, and clean gas systems. All tests are conducted in accordance with strict cGMP requirements. In addition various tests are routinely conducted to maintain an optimal working environment for producing products. For example, environmental monitoring, testing of the purified water for injection are conducted to sustain the optimal working environment |
1. Real time PCR (DNA dose) |
1. Sterility Test |
Consignment production of Drug Substance (DS)
and Drug Product (DP)
MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.
Aseptic filling Small/Large commercial and clinical |
Pre-shipment inspection Foreign substance inspection |
Quality control and storage application of pharmaceutical quality system (ICH Q10) |
CMO SERVICE
01 | We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials. |
02 | Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product. |
03 | MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how. |
CMO SERVICE PROCEDURE
Consulting and Inquires
|
MICROBIOTIX CO., LTD
IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)
TEL : 02. 6379. 2649
E-mail : mx@microbiotix.net
Copyright © MICROBIOTIX. All rights reserved.
INQUIRIES![]() |
MICROBIOTIX CO., LTD
IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)
TEL : 02. 6379. 2649 l E-mail : mx@microbiotix.net
Copyright © MICROBIOTIX. All rights reserved.